TY  - GEN
AU  - Badrising,Sushil
AU  - van der Noort,Vincent
AU  - van Oort,Inge M
AU  - van den Berg,H Pieter
AU  - Los,Maartje
AU  - Hamberg,Paul
AU  - Coenen,Jules L
AU  - van den Eertwegh,Alfons J M
AU  - de Jong,Igle J
AU  - Kerver,Emile D
AU  - van Tinteren,Harm
AU  - Bergman,Andries M
TI  - Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment
SN  - 1097-0142
PY  - 2014///0710
KW  - Aged
KW  - Androstenes
KW  - Androstenols
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Benzamides
KW  - Docetaxel
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Nitriles
KW  - Phenylthiohydantoin
KW  - Prostatic Neoplasms, Castration-Resistant
KW  - drug therapy
KW  - Survival Analysis
KW  - Taxoids
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Observational Study
UR  - https://doi.org/10.1002/cncr.28518
ER  -